Home

kiraya veren Heyecanlanın silindir lancet preprint kıvılcım Doğruyu söylemek gerekirse Araya girmek

For Authors: Submit your work
For Authors: Submit your work

Robustness of evidence reported in preprints during peer review - The Lancet  Global Health
Robustness of evidence reported in preprints during peer review - The Lancet Global Health

The Lancet Regional Health – Americas
The Lancet Regional Health – Americas

A new paradigm is needed to explain long COVID - The Lancet Respiratory  Medicine
A new paradigm is needed to explain long COVID - The Lancet Respiratory Medicine

Long-term outcomes following hospital admission for COVID-19 versus  seasonal influenza: a cohort study - The Lancet Infectious Diseases
Long-term outcomes following hospital admission for COVID-19 versus seasonal influenza: a cohort study - The Lancet Infectious Diseases

The Lancet Commission on lessons for the future from the COVID-19 pandemic  - The Lancet
The Lancet Commission on lessons for the future from the COVID-19 pandemic - The Lancet

For Authors: Submit your work
For Authors: Submit your work

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against  SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised  controlled trial - The Lancet
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial - The Lancet

For Authors: Submit your work
For Authors: Submit your work

Preprints with The Lancet: joining online research discussion platforms -  The Lancet
Preprints with The Lancet: joining online research discussion platforms - The Lancet

Preprints are the future but peer review is still king' - Research  Professional News
Preprints are the future but peer review is still king' - Research Professional News

The Lancet, 06 January 2024, Volume 403, Issue 10421, Pages 1-116, e1
The Lancet, 06 January 2024, Volume 403, Issue 10421, Pages 1-116, e1

The Lancet Microbe Home Page
The Lancet Microbe Home Page

Community transmission and viral load kinetics of the SARS-CoV-2 delta  (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a  prospective, longitudinal, cohort study - The Lancet Infectious Diseases
Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study - The Lancet Infectious Diseases

For Authors: Submit your work
For Authors: Submit your work

Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of  concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised  controlled trial - The Lancet
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial - The Lancet

First Look - SSRN | Elsevier
First Look - SSRN | Elsevier

A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization  response in COVID-19 convalescents, with a very good safety profile: An  open-label phase 1 clinical trial - The Lancet Regional Health – Americas
A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial - The Lancet Regional Health – Americas

The Lancet Oncology
The Lancet Oncology

Lancet COVID-19 Commission Statement on the occasion of the 75th session of  the UN General Assembly - The Lancet
Lancet COVID-19 Commission Statement on the occasion of the 75th session of the UN General Assembly - The Lancet

Reporting and data sharing level for COVID-19 vaccine trials: A  cross-sectional study - eBioMedicine
Reporting and data sharing level for COVID-19 vaccine trials: A cross-sectional study - eBioMedicine

The Lancet Global Health Home Page
The Lancet Global Health Home Page

How swamped preprint servers are blocking bad coronavirus research
How swamped preprint servers are blocking bad coronavirus research

Prepublication and clinical practice: challenges ahead
Prepublication and clinical practice: challenges ahead

Impact of COVID-19 vaccination on the risk of developing long-COVID and on  existing long-COVID symptoms: A systematic review - eClinicalMedicine
Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review - eClinicalMedicine

The Lancet on X: "NEW—Most reliable estimates to date suggest 1 in 8  COVID-19 patients develop #longCOVID symptoms. https://t.co/wechj5flvg  https://t.co/pT8lBAWS4g" / X
The Lancet on X: "NEW—Most reliable estimates to date suggest 1 in 8 COVID-19 patients develop #longCOVID symptoms. https://t.co/wechj5flvg https://t.co/pT8lBAWS4g" / X